The start-up co-founded by Dov Moran, the inventor of the USB key, has developed a complete digital system of assistance to diabetics. The patient raises his own insulin rate with a device connected to a mobile application and a cloud platform. Thousands of patients in India are already using this device, soon to be marketed in Europe.

“We did not plan to start a business, we just wanted to create a solution for our family members , Yiftah Ben Aharon told Israel21C online newspaper . Co-founder in 2013 of GlucoMe with Dov Moran , himself a diabetic, the two men have gained ambition and start to equip thousands of patients, particularly in India where the most populous country in the world has more than 70 million diabetics.

In recent months, the leading Indian healthcare provider, Apollo Sugar, has integrated the GlucoMe solution into its new national diabetes management program. An ergonomic, inexpensive solution that has seduced the Asian giant. In emerging countries, the situation is “dramatic”, considers  Angelica Khachaturova. Vice President of Marketing for GlucoMe points to “a lack of infrastructure, inadequate health care budgets and inadequate health insurance coverage. However, for these reasons, emerging markets are much more flexible and adapt more quickly to new technologies. “


Today, every patient receives a kit where there is a device to raise his insulin level. A smart device connected to an iOS or Android mobile application that records the patient’s different data (time of care, insulin level, frequency). All this information is then transmitted to a virtual clinic. GlucoMe is also working on a smart insulin pen, which will be connected and will be able to administer the exact dosage of insulin.

This cloud platform is equipped with artificial intelligence algorithms capable of analyzing but also alerting healthcare professionals to patients requiring immediate clinical intervention. On a daily basis, it may simply be a question of adjusting treatments or sending direct recommendations to patients. With this system, economies of scale are realized. The carers can follow up to ten times more patients.


There are dozens of glucose monitors around the world, but GlucoMe is the only one to offer tested, patented audio connectivity. With this system, GlucoMe devices can work with any smartphone model without depending on the availability of wired internet, Wi-Fi, Bluetooth or any other communication protocol. “By using audio connectivity, GlucoMe has been able to remove most of the expensive parts from the device and create a smart and inexpensive system. It is available in emerging markets where 75% of the diabetic population lives without any intelligent technology to cope with their condition, “says L’Usine Digitale Angelica Khachaturova.

Audio connectivity also allows a “passive” monitoring mode. “The effectiveness of the system is based on effective and very regular monitoring. That’s why the data is automatically captured by the microphone and transferred to the cloud for analysis, “ she explains.


In 2017, global spending on diabetes was about $ 727 billion and is expected to reach about $ 776 billion over the next two decades. A huge global market that GlucoMe tackles. In the United States , the FDA certification is underway and should be obtained by the end of 2018. In Europe, the GlucoMe device is already CE certified and ready to be marketed in different countries whose management was still the names. In full growth, the company is seeking commercial and strategic partnerships on all continents.